The success of Novo Nordisk is built on more than 100 years of innovation and commitment to patients. In short, our medical doctors play a key role in all the different stages of the drug development process.

Our medical doctors are at the very heart of our business. They develop new therapies for life-threatening diseases, manage clinical trials and are responsible for the safety of our medicines. Our medical doctors are responsible to share new insights with physicians and other healthcare professionals all over the world.

We currently employ over 700 medical doctors within three primary areas: Medical & Science, Global Medical Affairs, and Global Safety.

In Medical & Science, medical doctors are managing cross-organisational clinical research and development strategies for the medicine they are responsible for.

In later phases, they collaborate closely with other experts to interpret clinical trial data and participate in the reporting of data to health authorities.

They are also responsible for the publication of clinical trial data and interaction with scientific experts and health authorities to achieve the best possible clinical development programmes.

In Global Medical Affairs, medical doctors are an integral part of the development and commercialisation of new products.

They play a critical role in supporting our clinical activities, ensuring consistent communication across all phases in our clinical trial programmes, including material for medical education and for international congresses.

In addition, an important task is to provide guidance on disease areas and existing products to colleagues in order to ensure that the development of our marketing materials is based on the latest scientific data.

In Global Safety, medical doctors are monitoring adverse events reported in clinical trials and in the market to ensure that our products are of the highest quality and pose the lowest possible risk to patients. Medical doctors in Global Safety advise on relevant mitigating actions to prevent or minimise the adverse events. 

They also play a key role during signal detection and the preparation of periodic safety update reports, as well as answering requests from regulatory authorities and assisting in the filing process of new medicines.